WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016184432) TYRAMINE DERIVATIVE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/184432    International Application No.:    PCT/CN2016/082945
Publication Date: 24.11.2016 International Filing Date: 23.05.2016
IPC:
C07K 5/00 (2006.01), A61K 38/07 (2006.01), A61P 19/10 (2006.01), A61P 19/00 (2006.01), A61P 35/04 (2006.01), A61L 27/54 (2006.01)
Applicants: INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES [CN/CN]; Zhang, Xubin No.A2, Nan Wei Road, Xicheng District Beijing 100050 (CN)
Inventors: YANG, Xiaoxiao; (CN).
LIU, Junli; (CN).
LIN, Hao; (CN).
BAI, Guoliang; (CN).
WANG, Dexin; (CN).
CHEN, Xiaoguang; (CN).
JIN, Jing; (CN)
Priority Data:
201510271175.0 21.05.2015 CN
Title (EN) TYRAMINE DERIVATIVE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION THEREOF
(FR) COMPOSÉ DE DÉRIVÉ DE TYRAMINE, COMPOSITION PHARMACEUTIQUE CONTENANT CELUI-CI ET APPLICATION ASSOCIÉE
(ZH) 酪胺衍生物类化合物、其药物组合物及其用途
Abstract: front page image
(EN)Disclosed is a tyramine derivative compound, as shown in formula (I). Also disclosed are a pharmaceutical composition comprising the compound and an application of the pharmaceutical composition in preparing a drug for treating and/or preventing diseases related to osteoblasts.
(FR)La présente invention concerne un composé de dérivé de tyramine montré dans la formule (I). L'invention concerne également une composition pharmaceutique comprenant le composé et une application de la composition pharmaceutique dans la préparation d'un médicament pour le traitement et/ou la prévention de maladies liées aux ostéoblastes.
(ZH)公开了一种酰胺类化合物,如式(I)所示。还公开了包含该化合物的药物组合物,以及其在制备用于治疗和/或预防与成骨细胞相关疾病的药物中的用途。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)